About FDA
Number of positive findings added to the Whole Genome Sequencing database
Dictionary: This measure captures the total number of positive environmental samples processed using Whole Genome Sequencing techniques. Sequenced environmental samples can be compared to sequenced clinical samples for an opportunity to identify potential linkages with fewer illnesses or sparse EPI data.
Information is current as of March 31, 2023.
Fiscal Year - 2023

Time | Target | Number |
---|---|---|
Oct 2022 | N/A | 62 |
Nov 2022 | N/A | 6 |
Dec 2022 | N/A | 0 |
Jan 2023 | N/A | 0 |
Feb 2023 | N/A | 8 |
Mar 2023 | N/A | 32 |
Apr 2023 | N/A | TBD |
May 2023 | N/A | TBD |
Jun 2023 | N/A | TBD |
Jul 2023 | N/A | TBD |
Aug 2023 | N/A | TBD |
Sep 2023 | N/A | TBD |
FY 2023 YTD: 108
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.